To unlock this feature and to subscribe to our weekly evidence emails, please create a FREE orthoEvidence account.

SIGNUP

Already Have an Account?

Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Ace Report Cover

Combined IV and topical tranexamic acid reduces blood loss, not transfusion rate, in TKA

Download
Share
Reprints
Cite This
About
+ Favorites
Share
Reprints
Cite This
About
+ Favorites
Ace Report Cover
July 2016

Combined IV and topical tranexamic acid reduces blood loss, not transfusion rate, in TKA

Vol: 5| Issue: 7| Number:18| ISSN#: 2564-2537
Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:N/A

Combined Administration of Systemic and Topical Tranexamic Acid for Total Knee Arthroplasty: Can It Be a Better Regimen and Yet Safe? A Randomized Controlled Trial

J Arthroplasty. 2016 Feb;31(2):542-7

Contributing Authors:
NP Jain PP Nisthane NA Shah

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

Synopsis

119 patients scheduled for primary unilateral total knee arthroplasty were randomized to undergo the procedure either with combined intravenous and topical administration of tranexamic acid, or intravenous TXA administration alone. The purpose of this study was to compare total blood loss, allogeneic transfusion rate, hemoglobin drop, and the incidence of thromboembolic complications between group...

CME Image

Did you know that you’re eligible to earn 0.5 CME credits for reading this report!

LEARN MORE

Join the Conversation

Please Login or Join to leave comments.

Learn about our AI Driven
High Impact Search Feature

High Impact Icon

Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.

Continue